Jazz Pharmaceuticals Denmark ApS: Financial statements 2023
CVR: 39791447
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Jazz Pharmaceuticals Denmark ApS (CVR 39791447) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 31,787,838 and a net result of DKK 595,176 compared with DKK 1,972,936 the year before. That is an increase of 4.7% compared with the year before. Equity in the 2023 report amounted to DKK 10,756,897. The solvency ratio was 29.8%. The company had 17 employees in the financial year.
- Gross Profit
- DKK 31,787,838
- Profit/Loss
- DKK 595,176
- Equity
- DKK 10,756,897
- Total Assets
- DKK 36,081,398
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 31.8 mio. | 595 t. | 10.8 mio. | 17 |
| 2022 | - | 30.4 mio. | 2 mio. | 10.2 mio. | 16 |
| 2021 | - | 21.7 mio. | 560 t. | 8.2 mio. | 10 |
| 2020 | - | 16.5 mio. | 1.5 mio. | 7.6 mio. | 14 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Jazz Pharmaceuticals Denmark ApS has published its annual report for 2022. Gross profit came to DKK 30,364,239, and the net result was DKK 1,972,936.
About Jazz Pharmaceuticals Denmark ApS
Jazz Pharmaceuticals Denmark ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of David James Spackman and Kamilla Enggaard Have. The company is owned by Jazz Pharmaceuticals Ireland Holdings Limited. The company has 13 employees (2026). In 2025, the company reported a gross profit of DKK 41,044,332 and a net result of DKK 1,528,396 compared with DKK 1,538,214 the year before. Equity in the 2025 report amounted to DKK 13,823,507.